weight regain after stopping glp-1 agonists GLP‑1 medications can enable life transforming for loss, but what actually happens when you stop them? This newly published systematic review from University of Cambridge researchers gives us a clear answer New research from @doctorsigh shows

This variability in outcomes likely stems from differences in study design, population characteristics, and follow-up duration

Pennington Biomedical has the vision to lead the world in promoting nutrition and metabolic health and eliminating metabolic disease through scientific discoveries that create solutions from cells to society

PMID: 16410542

The LEADER and SUSTAIN-6 trials showed significantly higher levels of amylase and lipase in patients receiving liraglutide and semaglutide compared with placebo, but without a concomitant higher incidence of acute pancreatitis

Mechanism of Action Glucagon-like peptide-1 (GLP-1) is a member of the incretin family (gastrointestinal hormones released after meals that increase insulin secretion during periods of hyperglycaemia)